Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Arerugi = [Allergy]|July 2, 2008
[Effectiveness of inhaled corticosteroids (ics) combination therapy; the addition of qvar to flutide]Norihiro Kaneko, Yoshihiro Okuni, Yuko Tanabe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 9, 2024
Questionnaire survey of healthcare professionals on taxane-induced nail change in JapanKazumasa Yamamoto, Yuko Tanabe, Kiyomi Nonogaki, et al.
Molecular Autism|March 18, 2015
The association of GPR85 with PSD-95-neuroligin complex and autism spectrum disorder: a molecular analysisEriko Fujita-Jimbo, Yuko Tanabe, Zhiling Yu, et al.
Respiratory Investigation|September 7, 2021
Safety and harms of bronchoalveolar lavage for acute respiratory failure: A systematic review and meta-analysisKeisuke Anan, Yoshiyasu Oshima, Takayuki Ogura, et al.
Investigational New Drugs|July 31, 2012
Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I studyHajime Asahina, Hiroshi Nokihara, Noboru Yamamoto, et al.
Cancer Diagnosis & Prognosis|September 6, 2023
BRAF Mutation Heterogeneity Detected Using Circulating Tumor DNA Sequencing in Synchronous Colon Cancer: A Case ReportHaruka Kono, Taro Yamanaka, Yuki Nishihara, et al.
Asia-Pacific Journal of Clinical Oncology|May 22, 2025
Prognosis of Invasive Lobular Carcinoma and Effectiveness of Eribulin in Clinical Practice: A Post Hoc Analysis of a 2-Year Post-Marketing SurveillanceYuko Tanabe, Kenichi Inoue, Masato Takahashi, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2015
Phase 1 pharmacokinetic study of the oral pan-AKT inhibitor MK-2206 in Japanese patients with advanced solid tumorsToshihiko Doi, Kenji Tamura, Yuko Tanabe, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|August 15, 2008
[The efficacy of influenza vaccine for acute exacerbation of chronic obstructive lung disease in elderly patients]Eriko Ayabe, Norihiro Kaneko, Yoshihiro Ohkuni, et al.
Investigational New Drugs|August 28, 2016
Phase Ia/Ib study of the pan-class I PI3K inhibitor pictilisib (GDC-0941) administered as a single agent in Japanese patients with solid tumors and in combination in Japanese patients with non-squamous non-small cell lung cancerNoboru Yamamoto, Yutaka Fujiwara, Kenji Tamura, et al.
Pageof 11